N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation

European Journal of Neurology

Volumn 21, Issue 4, 2014, Pages 679-683

  Purroy, F ^a   Suarez Luis I ^a   Mauri Capdevila, G ^a   Cambray, S ^a   Farre J ^a   Sanahuja, J ^a   Pinol Ripoll G ^a   Quilez A ^a   Gonzalez Mingot C ^a   Begue R ^a   Gil, M I ^a   Fernandez E ^a   Benabdelhak, I ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

Atrial fibrillation; Biomarker; Cardioembolic; NT proBNP; Transient ischemic attack

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; NEURON SPECIFIC ENOLASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRANSIENT ISCHEMIC ATTACK; VERY ELDERLY;

ATRIAL FIBRILLATION; BIOMARKER; CARDIOEMBOLIC; NT-PROBNP; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PHOSPHOPYRUVATE HYDRATASE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 84897925920     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12222     Document Type: Article

References (15)

1. Purroy F, Montaner J, Molina CA, Delgado P, Ribo M, Alvarez-Sabin J. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke 2007; 38: 3225-3229.
2. Schnabel RB, Larson MG, Yamamoto JF, et al. Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 2010; 121: 200-207.
3. Rodriguez-Yanez M, Sobrino T, Blanco M, et al. High serum levels of pro-brain natriuretic peptide (pro BNP) identify cardioembolic origin in undetermined stroke. Dis Markers 2009; 26: 189-195.
4. Bai M, Yang J, Li Y. Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation. Clin Cardiol 2009; 32: E1-E5.
5. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-676.
6. Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 2007; 369: 283-292.
7. Purroy F, Begue R, Gil MI, et al. Patterns of diffusion-weighted magnetic resonance imaging associated with etiology improve the accuracy of prognosis after transient ischaemic attack. Eur J Neurol 2011; 18: 121-128.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
9. Di Angelantonio E, De Castro S, Toni D, et al. Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA. J Neurol Sci 2007; 260: 139-142.
10. Yukiiri K, Hosomi N, Naya T, et al. Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke. BMC Neurol 2008; 8: 45.
11. Okada Y, Shibazaki K, Kimura K, Iguchi Y, Miki T. Brain natriuretic peptide as a predictor of delayed atrial fibrillation after ischaemic stroke and transient ischaemic attack. Eur J Neurol 2010; 17: 326-331.
12. Tamura H, Watanabe T, Satoshi N, et al. Elevated plasma brain natriuretic peptide levels predict left atrial appendage dysfunction in patients with acute ischemic stroke. J Cardiol 2012; 60: 126-132.
13. Jensen JK, Mickley H, Bak S, Korsholm L, Kristensen SR. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc Dis 2006; 22: 439-444.
14. Fonseca AC, Matias JS, Pinho e Melo T, Falcao F, Canhao P, Ferro JM. N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke. Int J Stroke 2011; 6: 398-403.
15. Wu AH, Smith A, Wieczorek S, et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003; 92: 628-631.